EUVIMEDEUVIMED entdecken
Systematische ÜbersichtLeitlinieOpen Access · CC BY-NC 4.0

Management of bone health in cancer survivorship: a systematic review of clinical guidelines

Victor Ki Chung Li, Stirling Cosgrove, Katelyn Collins, Paul Baden, Richard Blennerhassett, Bryan A Chan, Li-Heng Chan, Daphne Day, Belinda Goodwin, Alastair Kwok, Debbie Packham, Kaung Tha Kyaw und 6 weitere

Osteoporosis International · 2026

DOI: 10.1007/s00198-026-07924-8 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Osteoporosis International, 2026. Verfasst von Victor Ki Chung Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms, Osteoporosis, Practice Guidelines as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deakin University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Accelerated bone loss is a side effect of many anticancer treatments, posing significant health challenges for cancer survivors. The aim of this systematic review was to evaluate and synthesize recommendations for the management of bone health, specifically fracture and osteoporosis risk, in clinical guidelines for people with cancer. METHODS: Searches related to bone health clinical guidelines for cancer patients were conducted in four electronic databases (PubMed, EMBASE, CINAHL, and Scopus). Data extraction was performed independently by multiple authors. Quality appraisal was performed using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument. Guidelines were categorized into three key focus areas (pharmacological interventions, screening, and lifestyle modifications) and compared across cancer types. RESULTS: A total of sixty-five guidelines were included in the systematic review. Two-thirds of guidelines included recommendations related to lifestyle (most commonly vitamin D and calcium supplementation), 76% related to screening (mostly bone mineral density via DXA), and 89% related to pharmacological intervention (most commonly bisphosphonates and denosumab). Fifty-four percent included recommendations in all three domains. Using the AGREE II tool, 42 guidelines were rated moderate and 23 high with strong scoring in domains of Scope and Purpose, Clarity of Presentation and Editorial Independence. CONCLUSIONS: Findings highlight variations in guideline quality, with many lacking holistic, multidisciplinary recommendations for bone health management. Further development of guidelines supporting patients impacted by multiple risk factors, and the inclusion of management strategies to mitigate compounding effects of cancer-related bone loss and age-related bone degradation among cancer patients, is recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsNeoplasmsOsteoporosisPractice Guidelines as TopicHumansAntineoplastic AgentsBone DensityBone Density Conservation AgentsLife StyleOsteoporotic Fractures

Stichwörter der Autor:innen

FractureOncologyOsteopeniaOsteoporosis

Substanzen

Antineoplastic AgentsBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Department of Oncology, Monash Health, Clayton, VIC, Australia.
  • School of Public Health, University of Queensland, Brisbane, QLD, 4072, Australia.
  • Cancer Council Queensland, Fortitude Valley, QLD, Australia.
  • School of Psychology and Wellbeing, University of Southern Queensland, Springfield, QLD, Australia.
  • Private Lived Experience Consultant, Melbourne, Australia.

Förderung

  • Deakin University

Zitieren

APA

Li, V. K. C., Cosgrove, S., Collins, K., Baden, P., Blennerhassett, R., Chan, B. A., Chan, L. H., Day, D., Goodwin, B., Kwok, A., Packham, D., Kyaw, K. T., Todaro, C., Webber, K., Williams, J., Zengin, A., Grech, L., & BHCS study team (2026). Management of bone health in cancer survivorship: a systematic review of clinical guidelines. Osteoporosis International. https://doi.org/10.1007/s00198-026-07924-8

Vancouver

Li VKC, Cosgrove S, Collins K, Baden P, Blennerhassett R, Chan BA, et al. Management of bone health in cancer survivorship: a systematic review of clinical guidelines. Osteoporosis International. 2026. doi:10.1007/s00198-026-07924-8

BibTeX
@article{Li2026,
  author = {Li, Victor Ki Chung and Cosgrove, Stirling and Collins, Katelyn and Baden, Paul and Blennerhassett, Richard and Chan, Bryan A and Chan, Li-Heng and Day, Daphne and Goodwin, Belinda and Kwok, Alastair and Packham, Debbie and Kyaw, Kaung Tha and Todaro, Christopher and Webber, Kate and Williams, Janne and Zengin, Ayse and Grech, Lisa and BHCS study team, BHCS study team},
  title = {Management of bone health in cancer survivorship: a systematic review of clinical guidelines},
  journal = {Osteoporosis International},
  year = {2026},
  doi = {10.1007/s00198-026-07924-8}
}
Kostenlos starten →